Dialogues in Clinical Neuroscience is a quarterly publication that aims to serve as an interface between clinical neuropsychiatry and the neurosciences by providing state-of-the-art information and original insights into relevant clinical, biological, and therapeutic aspects. Each issue addresses a specific topic, and authors are invited by the Editorial Board. All contributions are reviewed by members of the Editorial Board and submitted to expert consultants for peer review.
《临床神经科学对话》 (Dialogues in Clinical Neuroscience )是一份季刊,旨在通过提供最新信息和对相关临床、生物学和治疗方面的独到见解,作为临床神经精神病学和神经科学之间的接口。每一期都涉及一个特定的主题,作者由编辑委员会邀请。所有稿件均由编辑委员会成员审查,并提交给专家顾问进行同行审查。
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/hhampel
Unraveling the epigenetic landscape of depression: focus on early life stress\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/enestler
A review of epigenetic contributions \u2028to post-traumatic stress disorder\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/kressler
Domains of cognition and their assessment\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/pharvey
Dietary interventions in mild cognitive impairment and dementia
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dcns.2019.21.1/nscarmeas
Pharmacological treatment of cognitive deficits in nondementing mental health disorders\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/trobbins
Psychedelic drugs—a new era in\u2028psychiatry?\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/dnutt
The epigenetics of perinatal stress\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/mszyf
Antidiabetic therapies and Alzheimer disease
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dnc.2019.21.1/bbendlin
Treating psychiatric symptoms and disorders with non-psychotropic medications\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/vhede
Potential immunotherapy for Alzheimer disease and age-related dementia
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dcns.2019.21.1/mschwartz
Epigenetics and depression\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/ebinder
Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/amccleery
Metacognitive and cognitive-behavioral interventions for psychosis: new developments\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/smoritz
Cognition and addiction\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/gdom
The synaptic pathology of cognitive life\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/whoner
Dementia prevention and reserve against neurodegenerative disease
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.1/RPERNECZKY2
What are we trying to prevent in Alzheimer disease?
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.1/FJESSEN
Physical activity for cognitive health: what advice can we give to older adults with subjective cognitive decline and mild cognitive impairment?
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dcns.2019.21.1/nlautenschlager
Effects of computer gaming on cognition, brain structure, and function: a critical reflection on existing literature\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/skuehn
Genomics and the future of psychopharmacology: MicroRNAs offer novel therapeutics\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/dgurwitz
Drug discovery in psychopharmacology: from 2D models to cerebral organoids\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/jladewig
Ethical issues in early diagnosis and prevention of Alzheimer disease
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dnc.2019.21.1/pwhitehouse
Epigenetics as a key link between psychosocial stress and aging: concepts, evidence, mechanisms\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/azannas
Assessing behavior and cognition in rodents, nonhuman primates, and humans: where are the limits of translation?\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/mrossner
The “systems approach” to treating the brain: opportunities in developmental psychopharmacology\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/lloiacono
Receptor variants and the development of centrally acting medications\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/dbertrand
Prevention of dementia presents a potentially critical platform for improvement of long-term public health
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dcns.2019.21.1/mbeeri
Transcriptional mechanisms of drug addiction\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/pkenny
Is Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-old
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dcns.2019.21.1/vharoutunian
Dementia treatment versus prevention
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dnc.2019.21.1/rperneczky
Genetic and epigenetic editing in\u2028nervous system\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/jday
Nonpharmacological treatment of dyscognition in schizophrenia: effects \u2028of aerobic exercise\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/aschmitt
Use of the epigenetic toolbox\u2028to contextualize common variants associated with schizophrenia risk\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/sakbarian
Dysfunctional neurocognition in individuals with clinically significant psychopathic traits\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/rblair
Future paths in psychopharmacology\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/fthibaut
Harnessing the microbiota to treat neurological diseases\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/nsurana
How evolutionary psychiatry can advance psychopharmacology\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/rnesse
Opportunities and challenges in psychopharmacology\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.2/pschulz
Is dementia a preventable disease ?
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/dcns.2019.21.1/fthibaut
Cognition in psychiatry\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.3/fthibaut
Epigenetics: the missing link between genes and psychiatric disorders?\u2029
来源期刊:Dialogues in Clinical NeuroscienceDOI:10.31887/DCNS.2019.21.4/fthibaut